Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Myomo (MYO) over the last 8 years, with Q3 2025 value amounting to $103779.0.

  • Myomo's Asset Writedowns and Impairment changed N/A to $103779.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $193822.0, marking a year-over-year increase of 82155.76%. This contributed to the annual value of $43657.0 for FY2024, which is 5371.64% up from last year.
  • Myomo's Asset Writedowns and Impairment amounted to $103779.0 in Q3 2025.
  • Myomo's Asset Writedowns and Impairment's 5-year high stood at $103779.0 during Q3 2025, with a 5-year trough of -$374.0 in Q3 2023.
  • Its 4-year average for Asset Writedowns and Impairment is $31694.4, with a median of $20925.0 in 2022.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first plummeted by 5014.38% in 2023, then soared by 14342.31% in 2024.
  • Over the past 4 years, Myomo's Asset Writedowns and Impairment (Quarter) stood at $26075.0 in 2022, then tumbled by 39.5% to $15775.0 in 2023, then surged by 143.42% to $38400.0 in 2024, then skyrocketed by 170.26% to $103779.0 in 2025.
  • Its last three reported values are $103779.0 in Q3 2025, $51643.0 for Q1 2025, and $38400.0 during Q4 2024.